CoChat

Characterisation of liver fat in the UK Biobank cohort

Open access

The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.

Abstract

Non-alcoholic fatty liver disease and the risk of progression to steatohepatitis, cirrhosis and hepatocellular carcinoma have been identified as major public health concerns. We have demonstrated the feasibility and potential value of measuring liver fat content by magnetic resonance imaging (MRI) in a large population in this study of 4,949 participants (aged 45-73 years) in the UK Biobank imaging enhancement. Despite requirements for only a single (≤3min) scan of each subject, liver fat was able to be measured as the MRI proton density fat fraction (PDFF) with an overall success rate of 96.4%. The overall hepatic fat distribution was centred between 1-2%, and was highly skewed towards higher fat content. The mean PDFF was 3.91%, and median 2.11%. Analysis of PDFF in conjunction with other data fields available from the UK Biobank Resource showed associations of increased liver fat with greater age, BMI, weight gain, high blood pressure and Type 2 diabetes. Subjects with BMI less than 25 kg/m2 had a low risk (5%) of high liver fat (PDFF > 5.5%), whereas in the higher BMI population (>30 kg/m2) the prevalence of high liver fat was approximately 1 in 3. These data suggest that population screening to identify people with high PDFF is possible and could be cost effective. MRI based PDFF is an effective method for this. Finally, although cross sectional, this study suggests the utility of the PDFF measurement within UK Biobank, particularly for applications to elucidating risk factors through associations with prospectively acquired data on clinical outcomes of liver diseases, including non-alcoholic fatty liver disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0172921

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Representative MRI images from the UKBiobank cohort, showing individuals with 1%, 18% and 28% PDFF. Clear differences in the intensity of the liver can be seen, with the liver appearing brighter as PDFF increases.
Fig 1 Representative MRI images from the UKBiobank cohort, showing individuals with 1%, 18% and 28% PDFF. Clear differences in the intensity of the liver can be seen, with the liver appearing brighter as PDFF increases.CC BY · PubMed Central
Fig 2 Distribution of PDFF in whole cohort. There are 84 individuals with PDFF > 20%, who are not shown here. The darker part of each bar corresponds to the individuals with BMI > 25 kg/m2.
Fig 2 Distribution of PDFF in whole cohort. There are 84 individuals with PDFF > 20%, who are not shown here. The darker part of each bar corresponds to the individuals with BMI > 25 kg/m2.CC BY · PubMed Central
Fig 3 Relationship between proton density fat fraction and body mass index. PDFF is plotted on a log scale. 83 (1.8%) individuals are in the top left quadrant, 835 (18.1%) in the top right, 1983 (42.9%) in the bottom right and 1696 (36.7%) in the bottom left quadrant.
Fig 3 Relationship between proton density fat fraction and body mass index. PDFF is plotted on a log scale. 83 (1.8%) individuals are in the top left quadrant, 835 (18.1%) in the top right, 1983 (42.9%) in the bottom right and 1696 (36.7%) in the bottom left quadrant.CC BY · PubMed Central
Fig 4 Distribution of liver fat by age group and sex. The dashed line shows the population median PDFF (2.11%). *** indicates p < 0.001 from a two-sided K-S test. Significance lines are only shown for p <0.001.
Fig 4 Distribution of liver fat by age group and sex. The dashed line shows the population median PDFF (2.11%). *** indicates p < 0.001 from a two-sided K-S test. Significance lines are only shown for p <0.001.CC BY · PubMed Central
Fig 5 Box plots showing the distribution of PDFF for groups divided by several self-reported factors. Top left—Diabetes. Top right—Vascular problems. Bottom left—self-reported weight change over the year prior to imaging visit. *** indicates p < 0.001 and ** indicates p < 0.01 from a two-sided K-S test.
Fig 5 Box plots showing the distribution of PDFF for groups divided by several self-reported factors. Top left—Diabetes. Top right—Vascular problems. Bottom left—self-reported weight change over the year prior to imaging visit. *** indicates p < 0.001 and ** indicates p < 0.01 from a two-sided K-S test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 35 references

Cited by

See all 159

Metadata

Authors
Wilman, H. R., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A., Gyngell, M., Neubauer, S., Bell, J. D., Banerjee, R., & Thomas, E. L.
Affiliations
  • Perspectum Ltd. (United Kingdom) (GB)
  • UK Biobank (GB)
  • Imperial College London (GB)
  • University of Oxford (GB)
  • University of Westminster (GB)
Corresponding author
Thomas, E. Louise
Venue
PLOS ONE
Published
2017-02-27
Volume
12
Issue
2
Pages
e0172921
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2592225941
Cited by
159
References
37
Citations by year
2026: 11 · 2025: 19 · 2024: 28 · 2023: 23 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 5 · 2018: 13 · 2017: 4
FWCI
8.99
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • WestminsterResearch (University of Westminster) (acceptedVersion)
  • WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
Innovate UK (GB) (010271)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
liver fat, non-alcoholic fatty liver disease, proton density fat fraction, magnetic resonance imaging, UK Biobank, body mass index, type 2 diabetes, blood pressure, weight gain, mass screening, risk factors
MeSH terms
Adipose Tissue, Age Factors, Aged, Cross-Sectional Studies, Female, United Kingdom, Humans, Image Processing, Computer-Assisted, Liver, Liver Diseases, Magnetic Resonance Imaging, Male, Middle Aged, Phenotype, Prospective Studies, Risk Factors, Body Mass Index, Treatment Outcome, Biological Specimen Banks, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterisation of liver fat in the UK Biobank cohort. https://app.cochat.ai/papers/10.1371/journal.pone.0172921
The paper
Wilman, H. R., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A., Gyngell, M., Neubauer, S., Bell, J. D., Banerjee, R., & Thomas, E. L. (2017). Characterisation of liver fat in the UK Biobank cohort. PLOS ONE. https://doi.org/10.1371/journal.pone.0172921

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.